WallStreetZen

NYSE: ABT
Abbott Laboratories Stock Forecast, Predictions & Price Target

Analyst price target for ABT

Based on 10 analysts offering 12 month price targets for Abbott Laboratories.
Min Forecast
$120.00-3.73%
Avg Forecast
$130.30+4.53%
Max Forecast
$140.00+12.31%

Should I buy or sell ABT stock?

Based on 10 analysts offering ratings for Abbott Laboratories.
Strong Buy
Strong Buy
6 analysts 60%
Buy
3 analysts 30%
Hold
1 analysts 10%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

ABT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
BTIG
Top 9%
92
Strong BuyMaintains$136.00+9.11%2021-08-31
Morgan Stanley
Bottom 49%
49
Strong BuyMaintains$136.00+9.11%2021-07-23
Credit Suisse
Top 15%
86
BuyMaintains$130.00+4.29%2021-07-23
Raymond James
Top 8%
93
BuyMaintains$128.00+2.69%2021-07-23
SVB Leerink
Top 19%
82
HoldMaintains$128.00+2.69%2021-07-20
Wells Fargo
Top 9%
92
Strong BuyMaintains$135.00+8.30%2021-07-12
Anonymous
BTIG
Strong BuyMaintains$120.00-3.73%2021-06-02
Citigroup
Top 4%
97
Strong BuyMaintains$125.00+0.28%2021-06-02
Barclays
Top 22%
79
Strong BuyMaintains$125.00+0.28%2021-06-02
Cowen & Co.
Top 25%
76
BuyMaintains$140.00+12.31%2021-01-28

1 of 1

Forecast return on equity

Is ABT forecast to generate an efficient return?
Company
30.24%
Industry
28.03%
Market
2,556.64%
ABT's Return on Equity is forecast to be high in 3 years (30.24%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is ABT forecast to generate an efficient return on assets?
Company
14.05%
Industry
14.58%
Market
1,250.14%
ABT is forecast to generate lower Return on Assets (14.05%) than the US Medical Devices industry average (14.58%)
Forecast

ABT earnings per share forecast

What is ABT's earnings per share in the next 3 years based on estimates from 10 analysts?
Avg 1 year Forecast
$4.42+23.67%
Avg 2 year Forecast
$4.66+30.42%
Avg 3 year Forecast
$5.23+46.5%
ABT's earnings are forecast to grow at a rate of 12.88% per year, which is not exceptional
Forecast

ABT revenue forecast

What is ABT's revenue in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$39.8B-1.1%
Avg 2 year Forecast
$39.2B-2.58%
Avg 3 year Forecast
$41.8B+4%
ABT's revenue is forecast to grow at a rate of 0.74% per year, which is not exceptional
Forecast

ABT earnings growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
12.88%
Industry
24.94%
Market
18.71%
ABT's earnings are forecast to grow slower (12.88% per year) than the US Medical Devices industry average (24.94%)
Forecast
ABT's earnings are forecast to grow slower (12.88% per year) than the US market average (18.71%)
Forecast
ABT's earnings are forecast to grow faster (12.88% per year) than the risk-free savings rate (1.3%)
Forecast

ABT revenue growth forecast

How is ABT forecast to perform vs Medical Devices companies and vs the US market?
Company
0.74%
Industry
7.55%
Market
12.32%
ABT's revenues are forecast to grow slower (0.74% per year) than the US Medical Devices industry average (7.55%)
Forecast
ABT's revenues are forecast to grow slower (0.74% per year) than the US market average (12.32%)
Forecast

Abbott Laboratories Stock Forecast FAQ

Is Abbott Laboratories Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NYSE: ABT) stock is to Strong Buy ABT stock.

Out of 10 analysts, 6 (60%) are recommending ABT as a Strong Buy, 3 (30%) are recommending ABT as a Buy, 1 (10%) are recommending ABT as a Hold, 0 (0%) are recommending ABT as a Sell, and 0 (0%) are recommending ABT as a Strong Sell.

What is ABT's earnings growth forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's forecast annual earnings growth rate of 12.88% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.71%.

Abbott Laboratories's earnings in 2021 is $6,376,000,000.On average, 10 Wall Street analysts forecast ABT's earnings for 2021 to be $7,826,988,596, with the lowest ABT earnings forecast at $7,711,755,468, and the highest ABT earnings forecast at $7,906,765,377. On average, 10 Wall Street analysts forecast ABT's earnings for 2022 to be $8,254,237,577, with the lowest ABT earnings forecast at $8,066,318,938, and the highest ABT earnings forecast at $8,403,154,234.

In 2023, ABT is forecast to generate $9,271,834,735 in earnings, with the lowest earnings forecast at $9,112,281,174 and the highest earnings forecast at $9,342,747,429.

What is ABT's revenue growth forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's forecast annual revenue growth rate of 0.74% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.32%.

Abbott Laboratories's revenue in 2021 is $40,233,000,000.On average, 7 Wall Street analysts forecast ABT's revenue for 2021 to be $70,542,848,804,652, with the lowest ABT revenue forecast at $70,070,836,185,480, and the highest ABT revenue forecast at $71,052,746,530,571. On average, 7 Wall Street analysts forecast ABT's revenue for 2022 to be $69,488,908,890,671, with the lowest ABT revenue forecast at $67,832,672,010,541, and the highest ABT revenue forecast at $70,827,598,727,248.

In 2023, ABT is forecast to generate $74,180,301,258,791 in revenue, with the lowest revenue forecast at $71,805,715,243,212 and the highest revenue forecast at $76,961,546,754,788.

What is ABT's forecast return on assets (ROA) for 2021-2024?

(NYSE: ABT) forecast ROA is 14.05%, which is lower than the forecast US Medical Devices industry average of 14.58%.

What is ABT's Price Target?

According to 10 Wall Street analysts that have issued a 1 year ABT price target, the average ABT price target is $130.30, with the highest ABT stock price forecast at $140.00 and the lowest ABT stock price forecast at $120.00.

On average, Wall Street analysts predict that Abbott Laboratories's share price could stay at $130.30 by Aug 31, 2022. The average Abbott Laboratories stock price prediction forecasts a potential downside of N/A from the current ABT share price of $124.65.

What is ABT's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: ABT) Abbott Laboratories's current Earnings Per Share (EPS) is $3.57. On average, analysts forecast that ABT's EPS will be $4.42 for 2021, with the lowest EPS forecast at $4.35, and the highest EPS forecast at $4.46. On average, analysts forecast that ABT's EPS will be $4.66 for 2022, with the lowest EPS forecast at $4.55, and the highest EPS forecast at $4.74. In 2023, ABT's EPS is forecast to hit $5.23 (min: $5.14, max: $5.27).

What is ABT's forecast return on equity (ROE) for 2021-2024?

(NYSE: ABT) forecast ROE is 30.24%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.